Back to top
more

VANECK VECTORS PHARMACEUTICAL ETF: (PPH)

(Delayed Data from AMEX) As of Jul 29, 2016 03:59 PM ET

 Add to portfolio

$61.87 USD

61.87
41,462

+0.16 (0.26%)

Volume: 41,462

Zacks ETF Rank [?]: 2 - Buy   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 61.71
Open 61.74
Bid 61.06
Ask 62.25
Day Low-High 61.40-61.91
52wk Low-High 55.02-61.91
Volume 41,462
NAV (month end) 58.67
Premium (+)/Discount (-) (month end)+3.04

Zacks Premium Research for PPH

Zacks ETF Rank [?] Buy 2
ETF Risk [?] Med
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $1.40 (2.27%)
Issuer VAN ECK

Benchmark for PPH

MVIS US LISTED PHARMACEUTICAL 25 INDEX

The MVIS US Listed Pharmaceutical 25 Index tracks the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Fund Summary for PPH

VANECK VECTORS PHARMACEUTICAL ETF

The VanEck Vectors Pharmaceutical ETF replicates as closely as possible, before fees and expenses, the price and yield performance of MVIS US Listed Pharmaceutical 25 Index.